These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 20004289

  • 1. [Efficacy of escitalopram and severity of depression: new data].
    Spadone C.
    Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
    [Abstract] [Full Text] [Related]

  • 2. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P.
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [Abstract] [Full Text] [Related]

  • 3. [Severe forms of depression: the efficacy of escitalopram].
    Spadone C.
    Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
    Chauvet-Gélinier JC.
    Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633
    [Abstract] [Full Text] [Related]

  • 6. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH, Andersen HF, Thase ME.
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 8. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM, Llorca PM, Despiegel N, Verpillat P.
    Encephale; 2004 Nov; 30(2):158-66. PubMed ID: 15107719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of escitalopram compared to citalopram: a meta-analysis.
    Montgomery S, Hansen T, Kasper S.
    Int J Neuropsychopharmacol; 2011 Mar; 14(2):261-8. PubMed ID: 20875220
    [Abstract] [Full Text] [Related]

  • 11. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
    Gaillard R.
    Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM, Azorin JM, Despiegel N, Verpillat P.
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [Abstract] [Full Text] [Related]

  • 13. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
    Wade AG, Toumi I, Hemels ME.
    Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
    [Abstract] [Full Text] [Related]

  • 14. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H, Li T, Li G, Luo J.
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [Abstract] [Full Text] [Related]

  • 15. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 16. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U, Wade A, Andersen HF.
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [Abstract] [Full Text] [Related]

  • 17. Effective dose of escitalopram in moderate versus severe DSM-IV major depression.
    Bech P, Andersen HF, Wade A.
    Pharmacopsychiatry; 2006 Jul; 39(4):128-34. PubMed ID: 16871468
    [Abstract] [Full Text] [Related]

  • 18. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
    Moore N, Verdoux H, Fantino B.
    Int Clin Psychopharmacol; 2005 May; 20(3):131-7. PubMed ID: 15812262
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.
    Trivedi MH, Cutler AJ, Richards C, Lasser R, Geibel BB, Gao J, Sambunaris A, Patkar AA.
    J Clin Psychiatry; 2013 Aug; 74(8):802-9. PubMed ID: 24021497
    [Abstract] [Full Text] [Related]

  • 20. Superiority of escitalopram to paroxetine in the treatment of depression.
    Kasper S, Baldwin DS, Larsson Lönn S, Boulenger JP.
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.